Management of Papillary Thyroid Carcinoma After Hemithyroidectomy

Primary Recommendation: Completion Thyroidectomy

The National Comprehensive Cancer Network recommends completion thyroidectomy for patients with bilateral nodularity, regardless of favorable cancer features, due to the increased risk of contralateral disease 1
The presence of multiple nodules in the contralateral lobe overrides favorable cancer features and creates an absolute indication for completion thyroidectomy, as bilateral nodularity is an absolute indication for total thyroidectomy in papillary thyroid carcinoma 1

The American Joint Committee on Cancer and other guideline societies support the notion that bilateral nodularity mandates total thyroidectomy, regardless of the favorable features of the known cancer 1
Fine-needle aspiration cytology (FNAC) has limitations in distinguishing follicular neoplasms, and the presence of multiple nodules increases the probability of additional malignancy, highlighting the need for definitive pathologic evaluation 2, 3

The American Thyroid Association and other societies suggest that prophylactic central neck dissection is not mandatory in clinically and radiologically node-negative cases with favorable pathology, but therapeutic central neck dissection should be performed if suspicious lymph nodes are identified intraoperatively 1, 2, 3, 4

The American College of Endocrinology recommends careful examination of the completion thyroidectomy specimen to determine if additional foci of papillary carcinoma exist, which is found in 44% of cases 4, 2
Final risk stratification depends on complete pathologic findings from both lobes, including any additional tumor foci, multifocality, and lymph node status if dissection is performed, according to the National Comprehensive Cancer Network 4, 2
The Endocrine Society suggests considering radioactive iodine (RAI) ablation if there is macroscopic multifocal disease, as this would upgrade the risk category, and RAI ablation facilitates long-term surveillance by enabling thyroglobulin monitoring and whole-body scanning 1
The American Thyroid Association recommends initiating levothyroxine therapy to maintain TSH in the low-normal range for low-risk disease, or below 0.1 mU/L if higher-risk features are identified, and performing neck ultrasound every 6-12 months initially to monitor for locoregional recurrence 1, 4

The National Comprehensive Cancer Network (NCCN) recommends lobectomy for papillary thyroid carcinoma when tumor size is ≤4 cm, there is no extrathyroidal extension, no cervical lymph node metastases, no distant metastases, and no prior radiation exposure, representing a category 2B recommendation, meaning there is less uniform consensus but no major disagreement among guideline panel members 5
Lobectomy is acceptable for unifocal disease (no macroscopic multifocality) 5

The NCCN guidelines mandate total thyroidectomy if any of the following high-risk features are present: tumor >4 cm in diameter, extrathyroidal extension, cervical lymph node metastases, distant metastases, poorly differentiated histology, or prior radiation exposure 5
Total thyroidectomy is also recommended for bilateral nodularity or aggressive variants (tall cell, columnar cell, poorly differentiated features) 6

For papillary microcarcinomas, active surveillance has emerged as a viable first-line management strategy, particularly in elderly patients, according to the American College of Physicians 7
Lobectomy remains appropriate for microcarcinomas when surgery is chosen, provided no high-risk features exist, as per the European Society for Medical Oncology 8

The NCCN guidelines advise against performing lobectomy if preoperative ultrasound reveals suspicious cervical lymph nodes, intraoperative findings reveal extrathyroidal extension or multifocal disease, patient has history of head/neck radiation, or aggressive histologic variants are suspected on preoperative cytology 5
Completion thyroidectomy is not required for small volume pathologic N1A metastases or NIFTP (noninvasive follicular thyroid neoplasm with papillary-like nuclear features) pathologic diagnosis with negative margins and no contralateral lesion, as recommended by the American Thyroid Association 5

The NCCN guidelines recommend measuring thyroglobulin at 6-12 weeks postoperatively, considering levothyroxine therapy to maintain TSH in low-normal range, and ongoing surveillance with periodic thyroglobulin measurements and neck ultrasound after lobectomy for appropriate low-risk disease 5

In patients aged ≤30 years who have a history of head/neck radiation, the risk of multifocal and contralateral papillary thyroid carcinoma is markedly increased, supporting a total or near‑total thyroidectomy as the preferred initial operation. 9
When a thyroid nodule is ≥1 cm and any high‑risk feature (e.g., prior radiation, young age) is present, current guidelines advise that total or near‑total thyroidectomy should be performed rather than lobectomy. 9

Thyroid cancers arising after radiation exposure demonstrate higher rates of multifocality and bilateral disease, making limited resections such as lobectomy or subtotal thyroidectomy inadequate for disease control. 9
Subtotal thyroidectomy leaves residual thyroid tissue that hampers effective radioactive iodine (RAI) ablation and complicates long‑term surveillance, contrary to modern recommendations favoring total or near‑total resection. 9

For tumors approaching 4 cm in size and with a background of radiation exposure, RAI ablation is strongly indicated to eradicate residual thyroid tissue and treat potential microscopic disease. 9

A thorough preoperative neck ultrasound must be performed to assess cervical lymph‑node basins; if suspicious nodes are identified intraoperatively, a therapeutic central‑neck dissection should be carried out concurrently. 9